fortune gems gcash

fortune gems gcash WOONSOCKET, R.I. , Dec. 16, 2024 /PRNewswire/ -- CVS Health Corporation ("CVS Health" or the "Company,"NYSE: CVS ) announced today the applicable Reference Yields and Total Consideration (each as summarized in the tables below) to be paid in connection with the previously announced cash tender offer (the "Maximum Tender Offer" ) for the maximum principal amount of the following series of Maximum Tender Offer Notes (as defined below) for which the aggregate purchase price, not including Accrued Interest (as defined below), payable in respect of such Maximum Tender Offer Notes, does not exceed $1,774,423,242.62 (such maximum purchase price, the "Maximum Tender Offer Amount"): its 2.700% Senior Notes due 2040, the 3.875% Senior Notes due 2047 issued by its wholly-owned subsidiary Aetna Inc. ("Aetna"), its 4.250% Senior Notes due 2050, the 4.125% Senior Notes due 2042 issued by Aetna, its 4.125% Senior Notes due 2040, its 2.125% Senior Notes due 2031, its 1.875% Senior Notes due 2031, its 5.050% Senior Notes due 2048, the 4.500% Senior Notes due 2042 issued by Aetna and its 1.750% Senior Notes due 2030 (together, the "Maximum Tender Offer Notes"). The applicable Reference Yield for the Maximum Tender Offer Notes and the Total Consideration for the Maximum Tender Offer Notes are summarized in the table below: Maximum Tender Offer Notes : The Maximum Tender Offer is being made upon the terms and subject to the conditions set forth in the Offer to Purchase dated December 2, 2024 (as it may be amended or supplemented from time to time, the "Offer to Purchase"), which sets forth a more detailed description of the Maximum Tender Offer. Copies of the Offer to Purchase are available at www.dfking.com/cvs. The Maximum Tender Offer is open to all registered holders (individually, a "Holder" and collectively, the "Holders") of the Maximum Tender Offer Notes. The Total Consideration payable by CVS Health for the Maximum Tender Offer Notes is a price per $1,000 principal amount calculated as described in the Offer to Purchase in a manner intended to result in a yield to maturity or first par call date, as the case may be, equal to the sum of the yield to maturity of the applicable U.S. Treasury reference security specified in the table above as determined at 10:00 a.m. , New York City time, on December 16, 2024 and the applicable fixed spread shown in the table above. Maximum Tender Offer Notes that were tendered and not validly withdrawn at or prior to 5:00 p.m. , New York City time, on December 13, 2024 (the "Early Tender Date") and that are accepted for purchase will receive the applicable Total Consideration, which includes the Early Tender Payment (as defined in the Offer to Purchase). Maximum Tender Offer Notes that are tendered after the Early Tender Date but at or prior to 5:00 p.m. , New York City time, on December 31, 2024 (the "Maximum Tender Offer Expiration Date") (unless earlier terminated by CVS Health as described in the Offer to Purchase) and that are not validly withdrawn and that are accepted for purchase will receive only the applicable Tender Offer Consideration (as defined in the Offer to Purchase), which is the applicable Total Consideration minus the Early Tender Payment. The Maximum Tender Offer Withdrawal Deadline of 5:00 p.m. , New York City time, on December 13, 2024 has passed and, accordingly, Maximum Tender Offer Notes validly tendered in the Maximum Tender Offer may no longer be withdrawn. The settlement date for the Maximum Tender Offer Notes validly tendered at or prior to the Early Tender Date and accepted for purchase is expected to be December 18, 2024 , the third business day after the Early Tender Date (the "Early Settlement Date"). Although the Maximum Tender Offers is scheduled to expire at 5:00 p.m. , New York City time, on December 31, 2024 , unless extended or terminated, because the aggregate purchase price of Notes validly tendered (and not validly withdrawn) prior to the Early Tender Date exceeded the Maximum Tender Offer Amount, there is not expected to be a Final Settlement Date (as defined in the Offer to Purchase), and no Notes tendered after the Early Tender Date are expected to be accepted for purchase. In addition to the Total Consideration for the Maximum Tender Offer Notes, Holders of the Maximum Tender Offer Notes accepted for purchase on the Early Settlement Date will receive accrued and unpaid interest ("Accrued Interest") on those Maximum Tender Offer Notes from the last interest payment date with respect to those Maximum Tender Offer Notes to, but not including, the Early Settlement Date. CVS Health expressly reserves the right, in its sole discretion, subject to applicable law, to amend, extend or terminate the Maximum Tender Offer with respect to any or all series of Maximum Tender Offer Notes at any time if any condition to the Maximum Tender Offer is not satisfied. The Maximum Tender Offer is not conditioned on any minimum principal amount of Maximum Tender Offer Notes being tendered but the Maximum Tender Offer is subject to certain other general conditions as described in the Offer to Purchase. CVS Health has retained Barclays Capital Inc. and Mizuho Securities USA LLC to act as Dealer Managers for the Maximum Tender Offer. D.F. King & Co., Inc. has been retained to act as the Tender and Information Agent for the Maximum Tender Offer. The Offer to Purchase may be accessed at the following link: http://www.dfking.com/cvs . Requests for assistance relating to the procedures for tendering Maximum Tender Notes may be directed to the Tender and Information Agent either by email at [email protected] , or by phone (212) 269-5550 (for banks and brokers only) or (800) 487-4870 (for all others toll free). Requests for assistance relating to the terms and conditions of the Maximum Tender Offer may be directed to Barclays Capital Inc. at (800) 438-3242 (toll free) or (212) 528-7581 (collect) or Mizuho Securities USA LLC at (866) 271-7403 (toll-free) or (212) 205-7741. Beneficial owners may also contact their broker, dealer, commercial bank, trust company or other nominee for assistance. This press release does not constitute an offer to sell or purchase, or a solicitation of an offer to sell or purchase, or the solicitation of tenders with respect to, any securities, including the Maximum Tender Offer Notes. No offer, solicitation, purchase or sale will be made in any jurisdiction in which such an offer, solicitation, or sale would be unlawful. The Maximum Tender Offer is being made solely pursuant to the Offer to Purchase made available to Holders of the Maximum Tender Offer Notes. None of CVS Health, the Dealer Managers, Tender and Information Agent or the trustees with respect to the Maximum Tender Offer Notes, or any of their respective affiliates, is making any recommendation as to whether or not Holders should tender or refrain from tendering all or any portion of their Maximum Tender Offer Notes in response to the Maximum Tender Offer. Holders are urged to evaluate carefully all information in the Offer to Purchase, consult their own investment and tax advisers and make their own decisions whether to tender Maximum Tender Offer Notes in the Maximum Tender Offer, and, if so, the principal amount of Maximum Tender Offer Notes to tender. About CVS Health CVS Health is a leading health solutions company building a world of health around every consumer it serves and connecting care so that it works for people wherever they are. As of September 30, 2024 , the Company had more than 9,000 retail locations, more than 900 walk-in medical clinics, more than 225 primary care medical clinics, a leading pharmacy benefits manager with approximately 90 million plan members and expanding specialty pharmacy solutions, and a dedicated senior pharmacy care business serving more than 800,000 patients per year. The Company also serves an estimated more than 36 million people through traditional, voluntary and consumer-directed health insurance products and related services, including expanding Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan. The Company is creating new sources of value through its integrated model allowing it to expand into personalized, technology driven care delivery and health services, increasing access to quality care, delivering better health outcomes and lowering overall health care costs. Forward-Looking Statements This press release contains forward-looking statements. The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by or on behalf of CVS Health. By their nature, all forward-looking statements are not guarantees of future performance or results and are subject to risks and uncertainties that are difficult to predict and/or quantify. Actual results may differ materially from those contemplated by the forward-looking statements due to the risks and uncertainties described in our Securities and Exchange Commission filings, including those set forth in the Risk Factors section and under the heading "Cautionary Statement Concerning Forward-Looking Statements" in our most recently filed Annual Report on Form 10-K, our Quarterly Reports on Form 10-Q for the quarterly periods ended March 31, 2024 , June 30, 2024 and September 30, 2024 and our Current Reports on Form 8-K. You are cautioned not to place undue reliance on CVS Health's forward-looking statements. CVS Health's forward-looking statements are and will be based upon management's then-current views and assumptions regarding future events and operating performance, and are applicable only as of the dates of such statements. CVS Health does not assume any duty to update or revise forward-looking statements, whether as a result of new information, future events, uncertainties or otherwise. SOURCE CVS HealthI'm a Celeb stars can get a little-known exemption that lets them bring make-up into the campVenture capital in the U.S. has moved to artificial intelligence (AI) companies at an “unprecedented” rate, HSBC Innovation Banking said Monday (Dec. 16). The scale of capital invested in AI companies by U.S. venture investors is approaching that allocated to the rest of the venture market, the firm said in a Monday press release outlining findings from Innovation Horizons , its latest quarterly outlook for the U.S. technology sector. Forty-two percent of U.S. venture capital was invested into AI companies in 2024, up from 36 % in 2023 and 22 % in 2022, according to the report . The report also found that as of 2024, 20 AI companies have each raised $2 billion or more. “Venture capital has always gravitated toward transformative industries, but the level of consolidation we’re seeing within one category is unprecedented,” HSBC U.S. Innovation Banking Head Dave Sabow said in the release. “The radical change this investment will fuel places us in the dawn of ‘The Agentic Age,’ an era where autonomous artificial intelligence capabilities fundamentally redefine how we communicate, work and interface with digital and physical worlds.” Investment giant BlackRock said Dec. 7 that it expects 2025 to be a big year for infrastructure and cybersecurity, with the AI boom playing a major role in those investments. “It’s still very early in the AI adoption cycle,” Jay Jacobs , BlackRock’s U.S. head of thematic and active ETFs, told CNBC in a Dec. 7 report . Jacobs added that AI firms need to build out their data centers and that protecting that data will likely be a wise investment. The HSBC report came on the same day that SoftBank said it will invest $100 billion in the U.S. over the next four years, focusing on AI and related infrastructure. HSBC Innovation Banking also found in its report that R&D spending from the so-called Magnificent 7 companies totaled more than all the dollars invested in U.S. startups in 2024, according to the release. The Magnificent 7 are Tesla , Nvidia , Microsoft , Meta , Apple , Amazon and Alphabet . The firm also said in the release that it expects the U.S. tech sector to see new waves of growth and tailwinds for returns resulting from expected changes in the acquisition market, deregulation and fiscal policies that stimulate economic activity.

Shura Council reviews Ministry of Municipality’s strategy 2024-2030

Shares of Blackstone Mortgage Trust, Inc. ( NYSE:BXMT – Get Free Report ) have earned a consensus rating of “Hold” from the eight ratings firms that are presently covering the firm, Marketbeat Ratings reports. Five analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average twelve-month price target among analysts that have updated their coverage on the stock in the last year is $20.07. Several equities research analysts recently issued reports on BXMT shares. Wells Fargo & Company increased their target price on shares of Blackstone Mortgage Trust from $19.00 to $22.00 and gave the stock an “overweight” rating in a report on Friday, September 20th. Wolfe Research upgraded shares of Blackstone Mortgage Trust from a “peer perform” rating to an “outperform” rating and set a $20.00 price objective on the stock in a research report on Wednesday, December 11th. Check Out Our Latest Stock Analysis on BXMT Blackstone Mortgage Trust Stock Down 1.2 % Blackstone Mortgage Trust Announces Dividend The business also recently announced a quarterly dividend, which will be paid on Wednesday, January 15th. Investors of record on Tuesday, December 31st will be paid a dividend of $0.47 per share. The ex-dividend date is Tuesday, December 31st. This represents a $1.88 annualized dividend and a yield of 10.50%. Blackstone Mortgage Trust’s payout ratio is -135.25%. Institutional Inflows and Outflows Hedge funds and other institutional investors have recently made changes to their positions in the stock. Point72 Asset Management L.P. purchased a new stake in shares of Blackstone Mortgage Trust in the second quarter worth about $10,656,000. Prevail Innovative Wealth Advisors LLC bought a new stake in Blackstone Mortgage Trust in the 2nd quarter worth approximately $3,061,000. Intech Investment Management LLC purchased a new stake in shares of Blackstone Mortgage Trust during the 3rd quarter worth approximately $821,000. Tidal Investments LLC purchased a new position in shares of Blackstone Mortgage Trust in the third quarter valued at $883,000. Finally, Natixis Advisors LLC bought a new stake in Blackstone Mortgage Trust in the third quarter worth $211,000. Institutional investors own 64.15% of the company’s stock. About Blackstone Mortgage Trust ( Get Free Report Blackstone Mortgage Trust, Inc, a real estate finance company, originates senior loans collateralized by commercial properties in North America, Europe, and Australia. The company originates and acquires senior floating rate mortgage loans that are secured by a first-priority mortgage on commercial real estate assets. Further Reading Receive News & Ratings for Blackstone Mortgage Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Blackstone Mortgage Trust and related companies with MarketBeat.com's FREE daily email newsletter .

( MENAFN - GetNews) MIAMI - December 16, 2024 - KEO World (KEO), a fintech leader in B2B digital payments and inventory financing, today announced that it has taken a significant step in its expansion. Through a partnership agreement with BTG Pactual bank S.A., the largest investment bank in Latin America, KEO World will expand its operations in the Brazilian market. As part of the partnership, KEO's Workeo solution , in collaboration with the Amex Business Link Platform, can help thousands of medium and large businesses in Brazil digitize their B2B invoice payments, which can resulting significant cost efficiencies and increased purchasing power. Founded in 2020, KEO has experienced rapid growth. KEO's Workeo solution, powered by KEO's flagship credit processing, provides businesses with a working capital line of credit through a digital wallet within a multi-product payment and billing rails, available via Amex Business Link. Additionally, KEO offers its own proprietary blockchain payment rails, known as KEO Rails , to help make payments even easier. "We are delighted to have agreed to this partnership agreement with one of the largest financial institutions in South America, which will allow us to increase the reach of our B2B digital payments program and provide financing to many more companies in Brazil," said Paolo Fidanza , Founder and CEO of KEO. "In a market where less than 10% of total traditional credit is extended to SMEs, our Workeo product enables business buyers to access core inventory on credit and suppliers to increase their recurring sales, enhancing working capital management through a fully digital, frictionless, and low-cost financing and cash management platform thanks to our innovative payment rails, credit processing, and the American Express network." "Expanding the value proposition of the Amex Business Link platform is one of our priorities so that buyers and suppliers can make real-time decisions that optimize their working capital and improve their operational-administrative and reconciliation processes. Thanks to this expansion, companies in Brazil will be able to access an innovative and 100% digital ecosystem that offers digital payment and billing tools for local and international transactions", said René Centeno, American Express, Supply Chain Solutions Global Head. About KEO World Founded in 2020, KEO World is a leading innovator of technology-based financial solutions with a mission to provide businesses with digital, seamless and secure ways to finance their supplies and increase efficiency in their cash flow. KEO is headquartered in Miami, Florida, with operations in the US, Canada, Mexico, and throughout Latin America. The company was the first non-bank financial institution to receive an American Express issuing license. To learn more, visit . About American Express American Express is a globally integrated payments company that provides customers access to products, insights, and experiences that enrich lives and build business success. Learn more at americanexpress and connect with us at facebook/americanexpress instagram/americanexpress, linkedin/company/american-express, twitter/americanexpress and youtube/americanexpress. American Express® is a brand of American Express. Workeo is issued by KEO World S.A. de C.V., SOFOM, E.N.R. under license from American Express. KEO presents Workeo, a credit solution through the Amex Business Link platform. MENAFN16122024003238003268ID1108999823 Legal Disclaimer: MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Arm-Qualcomm Contract Fight Threatens to Upend Chip IndustryBlackstone Mortgage Trust, Inc. (NYSE:BXMT) Given Average Rating of “Hold” by AnalystsOAKLAND — Gov. Gavin Newsom held a news conference Friday to pressure Oakland officials to scale back a policy that only allows the cops to chase someone if there’s reasonable suspicion they have committed a violent crime. Calling the city’s policy an “extreme outlier,” Newsom first announced plans to extend a “surge” in California Highway Patrol support to combat retail theft, vehicle theft and sideshows in the East Bay. Then he said the popular program would only continue if the city meets him halfway. “We’re at that point in time that we need to see some commiserate support and changes as it relates to policing here in Oakland in order to consider extending that state-subsidized partnership,” Newsom said Friday, flanked by CHP officers, a local bishop and the city’s Chamber of Commerce CEO. He later added, “You can be drunk, you can run a red light, you can be close to side-swiping a school bus during the morning hours, right in front of a police officer, and the pursuit policy in Oakland says we cannot engage that suspect.” Newsom’s announcement comes just weeks after Oakland voters moved overwhelmingly to recall both the city’s mayor and the county’s district attorney, largely due to concerns over increases in property crimes. In a statewide landslide, voters also supported Proposition 36, a law opposed by Newsom, which opens up more avenues to charging shoplifters with a felony and imprisoning repeat offenders. “(Voters) want change. They’re demanding change,” Newsom said, referencing both recall elections. The CHP partnership program, implemented in 2023, simply adds officers to assist in specific “proactive” enforcement of property and nuisance crimes, like organized retail theft and sideshows. The governor’s office touted 1,400 arrests through the partnership this year, and says it resulted in $13 million in stolen goods being returned. The program has been seen as a band aid for cities with understaffed police departments, and exists in San Bernardino, Bakersfield and the Bay Area. CHP plans to extend its efforts in Vallejo as well, officials announced Friday. Newsom has attempted to convince Oakland leaders to do away with the pursuit policy before, including in an open letter to the city penned last July. The city’s police commission declined to recommend policy changes in September, citing the dangers of high-speed chases, but also concerns that most chases happen in the non-white, lower income parts of the city and that fewer chases would help build trust in those communities. Ironically, the policy doesn’t apply to CHP officers operating in Oakland, who say they’ve been met with surprise when they’ve chased suspects and forced them to stop.